Literature DB >> 26854328

Donor oocyte conception and pregnancy complications: a systematic review and meta-analysis.

Y B Jeve1,2, N Potdar2,3, A Opoku4, M Khare1.   

Abstract

BACKGROUND: Observational studies showed that women with a donor oocyte (DO) pregnancy have an increased risk of pregnancy complications.
OBJECTIVES: Systematic review and meta-analysis to compare pregnancy complications of DO pregnancy with autologous oocyte in vitro fertilisation (IVF), and whether DO pregnancy acts as an independent risk factor. SEARCH STRATEGY: Online searches of databases from 1 January 1980 to 31 January 2015 were performed using a set of relevant keywords. SELECTION CRITERIA: All studies comparing pregnancy complications of women with donor oocyte IVF and autologous oocyte IVF were included. DATA COLLECTION AND ANALYSIS: Data collected included demographics and pregnancy complications. Methodological quality assessment was performed using the Newcastle-Ottawa scale. Statistical analysis was performed using review manager 5.3 and stata 13.0. Meta-regression was performed for age. MAIN
RESULTS: In total, 11 studies (n = 81 752) were included. Ten studies (n = 11 539) examined the primary outcome. The risk of developing hypertensive disorders in pregnancy was significantly higher for DO pregnancy (odds ratio, OR 3.92; 95% confidence interval, 95% CI 3.21-4.78). Further subgroup analysis for singleton and twin pregnancies showed that the risk was significantly higher for DO pregnancy in each group. Secondary outcomes including small for gestational age (OR 1.81), caesarean section (OR 2.71), and preterm delivery (OR 1.34) were significantly higher with DO pregnancy. Meta-regression for the covariate of age suggested that risk was independent of age. AUTHOR'S
CONCLUSIONS: Donor oocyte pregnancy acts as an independent risk factor for pregnancy complications, including hypertensive disorders, small for gestational age, and preterm delivery. Women should be counselled carefully before undergoing DO-assisted conception. TWEETABLE ABSTRACT: Donor oocyte conception is an independent risk factor for obstetric complications.
© 2016 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Donor oocyte pregnancy; in vitro fertilisation; pre-elampsia; pregnancy-induced hypertension

Mesh:

Year:  2016        PMID: 26854328     DOI: 10.1111/1471-0528.13910

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  11 in total

Review 1.  Obstetric Complications of Donor Egg Conception Pregnancies.

Authors:  Amit Shah; Maryam Parisaei; Jessica Garner
Journal:  J Obstet Gynaecol India       Date:  2019-04-10

2.  Multifoetal gestations mediate the effect of in vitro fertilisation (IVF) on ischaemic placental disease in autologous oocyte IVF more than donor oocyte IVF.

Authors:  Anna M Modest; Louisa H Smith; Thomas L Toth; Ai-Ris Y Collier; Michele R Hacker
Journal:  Paediatr Perinat Epidemiol       Date:  2022-01-04       Impact factor: 3.980

3.  Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients.

Authors:  Yan Jiang; Jing-Chuan Yuan; Ge Song; Xu-Hui Zhang; Sui-Bing Miao; Xiao-Hua Wu
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-19       Impact factor: 3.105

4.  Uncomplicated oocyte donation pregnancies display an elevated CD163-positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches.

Authors:  Xuezi Tian; Kaveri T S Aiyer; Johanna M Kapsenberg; Dave L Roelen; Marie-Louise van der Hoorn; Michael Eikmans
Journal:  Am J Reprod Immunol       Date:  2021-12-04       Impact factor: 3.777

Review 5.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

6.  Association between infertility treatment and intrauterine growth: a multilevel analysis in a retrospective cohort study.

Authors:  Satoshi Shinohara; Shuji Hirata; Kohta Suzuki
Journal:  BMJ Open       Date:  2020-04-28       Impact factor: 2.692

Review 7.  Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Authors:  Filippo Maria Ubaldi; Danilo Cimadomo; Alberto Vaiarelli; Gemma Fabozzi; Roberta Venturella; Roberta Maggiulli; Rossella Mazzilli; Susanna Ferrero; Antonio Palagiano; Laura Rienzi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

Review 8.  Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring.

Authors:  Rachael Fox; Jamie Kitt; Paul Leeson; Christina Y L Aye; Adam J Lewandowski
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

9.  The Role of Macrophages in Oocyte Donation Pregnancy: A Systematic Review.

Authors:  Xuezi Tian; Michael Eikmans; Marie-Louise van der Hoorn
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

10.  What are the Predictive Factors for Preeclampsia in Oocyte Recipients?

Authors:  Céline Pimentel; Duros Solene; Jaffre Frédérique; Bouzille Guillaume; Leveque Jean; Le Lous Maëla
Journal:  J Hum Reprod Sci       Date:  2019-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.